Our state-of-the-art manufacturing facility coupled with our in-house research and development capability empowers us to offer a comprehensive range of solutions to customers.

Established in 1989, we are engaged In developing, manufacturing and supply of differentiated generic products In oral solid dosages alongside offering Pre Formulation Intermediates (PFI) and Finished Formulations (FF) for certain key therapeutic segments across rest of the world (RoW) markets. We are now focused on expanding our offerings across two verticals – pharmaceuticals and nutraceuticals, to customers across the globe.

We offer a range of non-infringing drug delivery solutions based on process technologies that allow us to improve patient compliance thereby reducing the cost of treatment.

Our differentiation and value proposition is in our ability to develop and supply combination generic products using various drug delivery techniques and release patterns in the oral solid dosage form.